DLD Asset Management’s Immunogen Inc IMGN Stock Holding History

DLD Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,000	Closed	-$1.63M	–	93
2023 Q4	$1.63M	Buy	+55,000	New	+$1.1M	0.2%	47
2019 Q2	–	Sell	-1,186,300	Closed	-$3.21M	–	111
2019 Q1	$3.21M	Buy	+1,186,300	New	+$5.14M	0.12%	57

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

DLD Asset Management's IMGN Position: Q1 2024 in Review

DLD Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 55,000 shares — an estimated $1.63M sold.

DLD Asset Management first reported a position in IMGN in Q1 2019 and held it in 2 quarters. The position peaked at $3.21M in Q1 2019. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

DLD Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
DLD Asset Management sold 55,000 Immunogen Inc shares in Q1 2024, an estimated $1.63M.
DLD Asset Management first reported a position in Immunogen Inc in Q1 2019 and held it in 2 quarters.
DLD Asset Management's Immunogen Inc position peaked at $3.21M in Q1 2019.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on DLD Asset Management's 13F filing for Q1 2024, filed 14 May 2024.